Oliver E. Hutt

Oliver E. Hutt

Auto-generated profile, based on publicly available information

Oliver E. Hutt

CSIRO Materials Science and Engineering, Bag 10, Clayton South MDC, VIC 3169 (Australia)

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2014 in Langmuir
Verified
Journal Article
Closed access
NBNicole Bye
Nicole Bye
OHOliver E. Hutt
Oliver E. Hutt
THTracey M. Hinton
Tracey M. Hinton
DADurga Acharya
Durga Acharya
LWLynne J. Waddington
Lynne J. Waddington
BMBenjamin W. Muir
Benjamin W. Muir

24 September 2019 in ACS Macro Letters
Verified
Journal Article
Closed access
LSLisa T. Strover
Lisa T. Strover
ACAlexis Cantalice
Alexis Cantalice
JLJeff Y. L. Lam
Jeff Y. L. Lam
APAlmar Postma
Almar Postma
OHOliver E. Hutt
Oliver E. Hutt
Graeme MoadGraeme Moad
Graeme Moad

2 September 2013 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
KTKristine J. Barlow (Née Tan)
Kristine J. Barlow (Née Tan)
XHXiaojuan Hao
Xiaojuan Hao
THTimothy C. Hughes
Timothy C. Hughes
OHOliver E. Hutt
Oliver E. Hutt
APAnastasios Polyzos
Anastasios Polyzos
Graeme MoadGraeme Moad
Graeme Moad
Herein we provide the first report of a new method for the preparation of porous functional poly(styrene-co-divinylbenzene) monoliths by use of reversible addition–fragmentation chain transfer (RAFT) polymerization. The method, exemplified by styrene–divinylbenzene copolymerization in the presence of 2-cyano-2-propyl dodecyl trithiocarbonate, provides control over polymerization kinetics, monolith morphology and surface functionality. Kinetic studies of monolith formation show a period of slow copolymerization, with a rate similar to RAFT homopolymerization of styrene, followed by rapid copolymerization, with a rate similar to that observed in conventional styrene–divinylbenzene copolymerization. The time to onset of rapid polymerization (gelation) and the monolith morphology depend strongly on the RAFT agent concentration. The RAFT-synthesized monoliths show a modified morphology with smaller pores and polymer globules when compared to non-RAFT monoliths, but importantly retain good flow properties. Retention of the thiocarbonylthio group within the monolith structure in an active form for surface-functionalization of the polymeric monoliths is demonstrated by the successful RAFT “grafting from” polymerization of (4-vinylphenyl)boronic acid. These functional monoliths have potential applications in chromatography and flow chemistry.

26 March 2013 in Organic Letters
Verified
Journal Article
Closed access
OHOliver E. Hutt
Oliver E. Hutt
TDTrinh L. Doan
Trinh L. Doan
GGGunda I Georg
Gunda I Georg

3 May 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
TSTina S Skinner-Adams
Tina S Skinner-Adams
GFGillian M. Fisher
Gillian M. Fisher
ARAndrew Riches
Andrew Riches
OHOliver E. Hutt
Oliver E. Hutt
KJKaren E. Jarvis
Karen E. Jarvis
KAKatherine T. Andrews
Katherine T. Andrews
Atovaquone-proguanil (Malarone®) is used for malaria prophylaxis and treatment. While the cytochrome bc1-inhibitor atovaquone has potent activity, proguanil’s action is attributed to its cyclization-metabolite, cycloguanil. Evidence suggests that proguanil has limited intrinsic activity, associated with mitochondrial-function. Here we demonstrate that proguanil, and cyclization-blocked analogue tBuPG, have potent, but slow-acting, in vitro anti-plasmodial activity. Activity is folate-metabolism and isoprenoid biosynthesis-independent. In yeast dihydroorotate dehydrogenase-expressing parasites, proguanil and tBuPG slow-action remains, while bc1-inhibitor activity switches from comparatively fast to slow-acting. Like proguanil, tBuPG has activity againstP. bergheiliver-stage parasites. Both analogues act synergistically with bc1-inhibitors against blood-stages in vitro, however cycloguanil antagonizes activity. Together, these data suggest that proguanil is a potent slow-acting anti-plasmodial agent, that bc1 is essential to parasite survival independent of dihydroorotate dehydrogenase-activity, that Malarone® is a triple-drug combination that includes antagonistic partners and that a cyclization-blocked proguanil may be a superior combination partner for bc1-inhibitors in vivo.

26 September 2011 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
MNMarsewi Ngatimin
Marsewi Ngatimin
RFRaphael Frey
Raphael Frey
CACecily Andrews
Cecily Andrews
DLDavid W. Lupton
David W. Lupton
OHOliver E. Hutt
Oliver E. Hutt
Vinylogous esters bearing para or metamethoxy benzyl groups undergo oxidative cyclisation with 5–20 mol% iodobenzene and m-CPBA to give spirofuran or benzopyran containing heterocycles. The reaction allows rapid generation of skeletal complexity in good to excellent yields via a novel oxidative cyclisation.